Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Clinical characteristics of patients with pneumatosis intestinalis

View through CrossRef
AbstractBackgroundSeveral theories explaining the development of pneumatosis intestinalis (PI) have been reported, but a substantial portion of cases have been idiopathic. Additionally, predictors of bowel ischaemia in PI have not been fully investigated, while PI with bowel ischaemia has deteriorated overall outcomes of PI.MethodsSixty‐four patients diagnosed with PI (2009–2019) were allocated to two groups: with (group 1;n = 15 (23%)) and without (group 2;n = 49 (77%)) bowel ischaemia. Fourteen patients underwent emergency surgery, and bowel ischaemia was identified in nine (64%). Six patients in group 1 were diagnosed with bowel ischaemia, and were treated palliatively. On medical charts, we determined underlying conditions of PI, compared the characteristics and outcomes between the groups, and identified the predictors of bowel ischaemia.ResultsGroup 1 patients more commonly showed abdominal pain, lower base excess, higher C‐reactive protein concentrations, higher white blood cell counts and higher neutrophil‐to‐lymphocyte ratios, and more frequent comorbid ascites, free air and hepatic portal vein gas. Of nine bowel ischaemia surgery patients, three (33%) died; all because of anastomotic leak. All except three patients in group 2, who presented with aspiration pneumonia, responded to treatment. Only one patient had an unknown cause (1/64, 1.6%), and various underlying conditions in secondary PI were confirmed.ConclusionIdiopathic PI may be identified rarely using current imaging and knowledge, but outcomes in PI patients with bowel ischaemia remain unsatisfactory. Earlier identification of bowel ischaemia by various specialists in accordance with predictors of bowel ischaemia could improve overall outcomes in PI patients.
Title: Clinical characteristics of patients with pneumatosis intestinalis
Description:
AbstractBackgroundSeveral theories explaining the development of pneumatosis intestinalis (PI) have been reported, but a substantial portion of cases have been idiopathic.
Additionally, predictors of bowel ischaemia in PI have not been fully investigated, while PI with bowel ischaemia has deteriorated overall outcomes of PI.
MethodsSixty‐four patients diagnosed with PI (2009–2019) were allocated to two groups: with (group 1;n = 15 (23%)) and without (group 2;n = 49 (77%)) bowel ischaemia.
Fourteen patients underwent emergency surgery, and bowel ischaemia was identified in nine (64%).
Six patients in group 1 were diagnosed with bowel ischaemia, and were treated palliatively.
On medical charts, we determined underlying conditions of PI, compared the characteristics and outcomes between the groups, and identified the predictors of bowel ischaemia.
ResultsGroup 1 patients more commonly showed abdominal pain, lower base excess, higher C‐reactive protein concentrations, higher white blood cell counts and higher neutrophil‐to‐lymphocyte ratios, and more frequent comorbid ascites, free air and hepatic portal vein gas.
Of nine bowel ischaemia surgery patients, three (33%) died; all because of anastomotic leak.
All except three patients in group 2, who presented with aspiration pneumonia, responded to treatment.
Only one patient had an unknown cause (1/64, 1.
6%), and various underlying conditions in secondary PI were confirmed.
ConclusionIdiopathic PI may be identified rarely using current imaging and knowledge, but outcomes in PI patients with bowel ischaemia remain unsatisfactory.
Earlier identification of bowel ischaemia by various specialists in accordance with predictors of bowel ischaemia could improve overall outcomes in PI patients.

Related Results

Colonic stenting for malignant colonic obstruction with pneumatosis intestinalis
Colonic stenting for malignant colonic obstruction with pneumatosis intestinalis
ABSTRACT INTRODUCTION: Pneumatosis intestinalis is one of serious conditions following mechanical bowel obstruction. Emer...
Differential management of Pneumatosis Intestinalis (PI)
Differential management of Pneumatosis Intestinalis (PI)
Abstract Pneumatosis intestinalis (PI) is a rare but potentially serious gastrointestinal condition with diverse clinical presentations. PI is identified by the presence of...
Case Report: An unusual case of small bowel volvulus associated with pneumatosis intestinalis
Case Report: An unusual case of small bowel volvulus associated with pneumatosis intestinalis
Pneumatosis cystoid intestinalis is a rare disease reported in the literature affecting 0.03% of the population. It has a variety of causes and its manifestation may change widely....
CASE REPORT OF A CHALLENGING CYSTIC INTESTINAL PNEUMATOSIS OF THE SMALL GUT ASSOCIATED WITH ULCER PERFORATION
CASE REPORT OF A CHALLENGING CYSTIC INTESTINAL PNEUMATOSIS OF THE SMALL GUT ASSOCIATED WITH ULCER PERFORATION
Introduction:-Cystic Intestinal Pneumatosis represents a challenging clinical condition with various clinical onsets and complications. Altogether, CIP is prone to misdiagnosis and...
Recurrent Benign Pneumatosis Intestinalis in a Patient With Mixed Connective Tissue Disease
Recurrent Benign Pneumatosis Intestinalis in a Patient With Mixed Connective Tissue Disease
Connective tissue diseases can be associated with rare gastrointestinal complications such as pneumatosis intestinalis and pneumoperitoneum. In this article, we report a unique cas...
Pneumatosis Intestinalis Detected by Point of Care Ultrasound, Case Report
Pneumatosis Intestinalis Detected by Point of Care Ultrasound, Case Report
Pneumatosis intestinalis (PI) is characterized by the presence of air within the walls of the small intestine, large intestine, and sometimes the gastric wall. The mechanism and pa...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract Introduction Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...

Back to Top